Abstract:Since, after the successful approval of albumin-based nanodrug "Abraxane" by food and drug administration (FDA) in 2005, considerable interests have been gained by protein-based nanoparticles in the field nanomedicine for cancer therapy. In recent years, various protein-based nanodevices have been developed; amid them, serum albumin as an intrinsic constituent of blood with no immunogenicity and toxicity regarded as an ideal tool to cargo and deliver diagnostic and therapeutic modalities to breast cancer cells simultaneously, named as theranostic. Serum albumin-based nanodevices are commonly loaded or conjugated with near infrared (NIR dyes), contrast agents, radionuclides, photosensitizers and organic or inorganic nanoclusters and chemotherapeutic agents. In general, serum albumin nanodevices offer several advantages such as biocompatibility, biodegradability, prolonged blood circulation, escape clearance by macrophages and surface modification with drugs or targeted ligand. Moreover, it can be easily prepared without using any toxic organic solvent or chemical agents. In addition, the nanoscale size of devices also facilitates the deep penetration into tumor tissue. This mini-review embodies general overview of albumin and its properties, tumor targeting mechanism and designed formulations, along with their applications in breast cancer diagnosis and therapy from the recent literature. Finally, the current challenges and future perspective are identified for translating serum albumin-based nanodevices from laboratory to clinical application. Graphical abstract Download : Download high-res image (218KB) Download : Download full-size image

Harnessing albumin as a carrier for cancer therapies

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy

Application of Albumin in Nanodrugs for Cancer Therapy

Albumin-based drug delivery: harnessing nature to cure disease

Protein Nanoparticles Directed Cancer Imaging and Therapy

Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy

Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy

Albumin Nanoparticle Encapsulation of Potent Cytotoxic Therapeutics Shows Sustained Drug Release and Alleviates Cancer Drug Toxicity.

The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics

Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Albumin-based nanodevices for breast cancer diagnosis and therapy

Revolutionizing breast cancer treatment: Harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles

Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy

Exploiting Albumin as a Versatile Carrier for Cancer Theranostics

Inflammation-Targeted Drug Delivery Strategies via Albumin-Based Systems

GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs

Human serum albumin binders: A piggyback ride for long-acting therapeutics

Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions

Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin

Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemia